MMSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
MERIT MEDICAL SYSTEMS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$89.96+0.76 (+0.85%)
Close on Oct 19, 2026
- Market cap
- $5.40B
- P/E (TTM)
- 37.2
- Dividend yield
- –
MERIT MEDICAL SYSTEMS INC revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endoscopy | – | – | $72.86M | $70.27M | $69.52M | $61.27M | $54.77M | $46.60M | $38.76M | $37.35M | $36.81M | $35.26M | – | – |
| Cardiovascular | – | – | $1.44B | $1.41B | $1.36B | $1.33B | $1.30B | $1.28B | $1.26B | $1.25B | $1.22B | $1.19B | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endoscopy | – | – | $18.59M | $12.75M | $7.63M | $5.02M | $5.54M | $7.89M | $10.70M | $10.02M | $9.50M | $8.62M | – |
| Cardiovascular | – | – | $166.13M | $154.34M | $154.11M | $155.78M | $150.15M | $144.85M | $139.92M | $123.47M | $114.44M | $112.13M | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $947.39M | $922.42M | $909.47M | $884.77M | $860.67M | $828.25M | $800.78M | $775.79M | $756.81M | $741.72M | $726.99M | $706.77M | 60.0% | +10.1% |
| International | $631.43M | $620.01M | $606.44M | $592.36M | $572.15M | $560.11M | $555.73M | $550.08M | $544.45M | $541.59M | $530.38M | $519.50M | 40.0% | +10.4% |
From the segment and revenue-disaggregation notes of Merit Medical Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.